Top Brand
Salt CompositionOur Recommendation
Unitinib 400mg Capsule
82+ trust this
WHO GMP Certified
82+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Blood cancer (Chronic myeloid leukaemia) / Blood cancer (Acute lymphocytic leukemia) / Gastrointestinal stromal tumour
Customers also bought
More About Unitinib
Benefits
In Blood cancer (Chronic myeloid leukaemia) Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Unitinib 400mg Capsule kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. In Blood cancer (Acute lymphocytic leukemia) Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Unitinib 400mg Capsule kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. In Gastrointestinal stromal tumour A gastrointestinal stromal tumor (GIST) is a type of tumor that occurs most commonly in the stomach or small intestine. The tumors develop into the specialized cells called interstitial cells of Cajal (ICCs). Unitinib 400mg Capsule helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor?s instructions carefully to get the most benefit.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Unitinib 400mg Capsule is to be taken with food.
How it works
Unitinib 400mg Capsule is an anti-cancer medication. A protein enzyme, bcr-abl tyrosine kinase, responsible for the growth of abnormal proliferation of cancer cells. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in bcr-abl positive cells (cancer cells). This is how it works to stop or slow the spread of cancer.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Unitinib 400mg Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Unitinib 400mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Seek medical advice from your doctor: Unitinib 400mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Lactating women should not breastfeed while using this drug and one month after stopping it.
Not Safe: Unitinib 400mg Capsule may cause side effects which could affect your ability to drive.
Caution Advised: Unitinib 400mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Unitinib 400mg Capsule may be needed. Doctor consultation is advised.
Caution Advised: Unitinib 400mg Capsule should be used with caution in patients with severe liver disease. Dose adjustment of Unitinib 400mg Capsule may be needed. Doctor consultation is advised.
What if I forget to take it?
If you forget a dose of Unitinib 400mg Capsule , simply continue with your regular schedule and do not take a double dose.
Manufacturer Address
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044
References
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1732-34
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 953
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 692-94
Imatinib mesylate. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2001 (23 Jan. 2019)
Drugs and Lactation Database (LactMed) (18 Feb. 2020)
Central Drugs Standard Control Organisation (CDSCO) (26 Mar. 2019)
Natco Pharma Limited. Safety Data Sheet: Imatinib Mesylate. 2019 (05 Jul. 2023)
CiplaMed. Imatinib mesylate (05 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.